Literature review shows safe, effective outcomes in haemophilia management, suggesting further investigation needed.
The association of nonfactor prophylaxis with recombinant factors has provided safe, reproducible and effective results, with low rates of complications. However, the experience with rebalancing agents is still limited, and more real-world studies are needed to confirm the most appropriate approach.
No takes yet. Share an insight, caveat, or question.
Carulli et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: